background
exacerb
childhood
asthma
rhinoviru
infect
peak
spring
fall
suggest
viral
infect
major
contributor
season
asthma
morbid
object
sought
evalu
rhinoviru
infect
peak
season
children
asthma
analyz
relationship
viral
infect
ill
sever
method
fiftyeight
children
age
year
asthma
provid
consecut
weekli
nasal
lavag
sampl
septemb
april
symptom
medic
use
peak
flow
record
rhinovirus
identifi
use
multiplex
pcr
partial
sequenc
viral
genom
result
virus
detect
specimen
virus
rhinovirus
differ
strain
includ
human
rhinoviru
c
among
rhinoviru
isol
strain
found
collect
period
children
respiratori
tract
infect
virusposit
week
associ
greater
cold
asthma
symptom
sever
p
p
respect
furthermor
virusposit
ill
increas
durat
sever
cold
asthma
symptom
frequent
loss
asthma
control
vs
p
although
allergensensit
versu
nonsensit
children
number
viral
infect
former
symptomat
viral
ill
vs
per
month
p
conclus
rhinoviru
infect
nearli
univers
children
asthma
common
cold
season
like
plethora
new
strain
appear
season
ill
associ
virus
greater
durat
sever
final
atop
asthmat
children
experienc
frequent
sever
virusinduc
ill
j
allergi
clin
immunol
predict
peak
asthma
exacerb
spring
fall
temper
climat
exampl
regular
season
cycl
asthma
hospit
schoolag
children
canada
demonstr
period
factor
contribut
septemb
epidem
asthma
morbid
children
like
includ
return
school
concord
exposur
virus
allerg
sensit
togeth
exposur
relev
airborn
allergen
despit
close
relationship
human
rhinoviru
hrv
infect
asthma
exacerb
relationship
infect
sever
clinic
ill
complet
understood
exampl
hrv
caus
asymptomat
infect
common
cold
exacerb
asthma
gap
knowledg
partli
relat
difficulti
detect
hrv
earli
studi
hrv
epidemiolog
use
diagnost
base
tissu
cultur
insensit
recent
studi
use
pcr
molecular
techniqu
indic
new
branch
hrv
famili
tree
one
characterist
recent
detect
hrvc
speci
detect
use
standard
tissu
cultur
new
molecular
assay
make
possibl
conduct
epidemiolog
studi
identifi
evalu
role
specif
strain
includ
hrvc
activ
chronic
asthma
exampl
recent
studi
detect
hrvc
almost
half
children
hospit
rhinovirusassoci
respiratori
tract
ill
addit
limit
relat
viral
diagnost
previou
studi
focus
detect
hrv
period
ill
littl
inform
true
rate
infect
asymptomat
lack
data
relat
mild
asymptomat
ill
hamper
effort
identifi
host
viral
factor
contribut
sever
ill
base
previou
find
children
hospit
seen
acutecar
facil
hypothes
viral
infect
allerg
sensit
contribut
loss
asthma
control
peak
hrv
season
allerg
children
hrv
infect
would
greatest
risk
goal
studi
prospect
evalu
contribut
hrv
season
asthma
diseas
activ
compar
clinic
characterist
viral
nonvir
ill
accomplish
goal
monitor
viral
infect
children
asthma
peak
common
cold
season
abbrevi
use
hrv
human
rhinoviru
pef
peak
expiratori
flow
virolog
inform
compar
pattern
upper
lower
respiratori
tract
ill
allerg
sensit
cold
asthma
diseas
activ
studi
approv
human
subject
committe
school
medicin
public
health
univers
wisconsinmadison
written
inform
consent
obtain
parent
studi
particip
fiftyeight
children
age
year
asthma
enrol
studi
skin
prick
test
perform
subject
time
enrol
well
fluoroenzym
immunoassay
autom
instrument
unicap
phadia
uppsala
sweden
determin
total
allergenspecif
ige
level
plasma
allergen
evalu
mean
skin
prick
test
alternaria
speci
tree
fluid
cladosporium
speci
grass
mix
aspergillu
speci
ragwe
dermatophagoid
farina
dermatophagoid
pteronyssinu
weed
mix
dog
dander
cat
dander
cockroach
greer
laboratori
lenoir
nc
addit
allergenspecif
ige
level
farina
pteronyssinu
cat
dog
alternaria
speci
ragwe
silver
birch
timothi
grass
cockroach
egg
peanut
measur
immunocap
feia
phadia
april
nasal
sampl
collect
everi
week
total
week
high
frequenc
distinct
infect
specimen
collect
increas
five
specimen
weekli
interv
septemb
april
children
parent
record
inform
daili
diari
card
diari
card
consist
calendar
day
space
place
sticker
cold
asthma
symptom
well
blank
record
morn
peak
expiratori
flow
pef
albuterol
use
sampl
includ
viral
analysi
comparison
rate
infect
respiratori
symptom
includ
children
collect
sequenti
weekli
nasal
specimen
miss
less
week
diari
card
data
given
season
children
enrol
children
complet
seri
inform
includ
final
analys
children
complet
least
season
complet
season
first
studi
visit
subject
taught
collect
sampl
nasal
mucu
use
noseblow
techniqu
briefli
particip
spray
salin
nostril
altern
occlud
nare
blew
baggi
two
millilit
solut
contain
buffer
salin
ph
along
gelatin
ad
baggi
seal
place
contain
freezer
studi
materi
diari
distribut
home
biweekli
collect
stabil
hrv
collect
store
condit
confirm
preliminari
experi
hrv
detect
even
low
concentr
pfu
per
millilit
might
seen
asymptomat
children
sampl
left
room
temperatur
refriger
home
freezer
week
diagnost
virolog
perform
nasal
sampl
irrespect
whether
child
symptom
highli
sensit
multiplex
pcrbase
assay
respiratori
multicod
assay
eragen
bioscienc
madison
wi
use
test
follow
virus
respiratori
syncyti
viru
group
b
hrv
parainfluenza
influenza
b
adenoviru
b
c
e
coronaviru
sar
enteroviru
human
metapneumoviru
bocaviru
detect
primer
also
ad
respiratori
multicod
assay
mixtur
purpos
studi
molecular
type
hrv
perform
previous
describ
briefli
variabl
region
noncod
region
hrv
amplifi
cdna
nasal
specimen
mean
seminest
pcr
fragment
clone
sequenc
ident
sequenc
verifi
mean
comparison
sequenc
refer
hrv
serotyp
well
number
sequenc
newli
identifi
strain
parent
children
score
cold
asthma
symptom
sever
base
score
system
none
mild
moder
sever
cold
symptom
defin
follow
mild
mild
stuffi
runni
nose
affect
daili
activ
moder
moder
stuffi
runni
nose
reduc
activ
affect
sleep
sever
breath
nose
abl
sleep
well
symptom
asthma
symptom
defin
follow
mild
occasion
cough
wheez
affect
daili
activ
moder
frequent
cough
wheez
short
breath
reduc
activ
affect
sleep
sever
abl
sleep
well
symptom
person
best
pef
subject
defin
averag
highest
daili
pef
valu
studi
period
asthma
control
defin
use
current
nation
guidelin
base
symptom
pef
albuterol
use
criteria
loss
asthma
control
consist
least
moder
asthma
symptom
either
decreas
pef
use
albuterol
day
per
week
two
method
use
analyz
associ
infect
ill
first
week
wednesday
follow
tuesday
design
viru
posit
neg
basi
viral
detect
result
nasal
mucu
sampl
obtain
saturday
presenc
cold
symptom
weekli
interv
compar
viral
detect
data
second
identifi
episod
infect
ill
base
virolog
find
clinic
symptom
respect
either
could
last
longer
singl
week
infect
identifi
evalu
result
molecular
type
viru
detect
multipl
week
consid
singl
infect
episod
respiratori
tract
ill
could
viral
nonvir
defin
least
consecut
day
cold
asthma
symptom
rate
least
mild
sever
patient
nasal
mucu
sampl
collect
everi
day
therefor
bisect
week
assum
ill
associ
viru
sign
ill
present
within
day
specimen
show
posit
test
result
viru
associ
viral
detect
symptom
complex
instanc
follow
dataprocess
rule
establish
priori
defin
viral
ill
symptomat
period
classifi
separ
ill
interv
without
symptom
differ
virolog
find
within
period
continu
symptom
classifi
ill
peak
cold
asthma
symptom
score
compar
viru
recoveri
x
test
trend
categor
outcom
analyz
fisher
exact
test
differ
continu
outcom
assess
use
wilcoxon
rank
sum
test
level
test
result
regard
statist
signific
children
asthma
enrol
studi
provid
least
complet
season
nasal
specimen
diari
card
data
includ
final
ill
analys
major
subject
persist
asthma
requir
daili
control
therapi
use
oral
corticosteroid
reliev
acut
asthma
symptom
year
lead
studi
observ
trial
treatment
asthma
continu
per
child
regular
physician
children
sensit
least
aeroallergen
indic
skin
test
serum
allergenspecif
ige
measur
demograph
baselin
fev
similar
complet
complet
studi
procedur
tabl
sampl
collect
specimen
posit
test
result
virus
season
fig
children
viru
detect
point
time
sampl
posit
test
result
hrv
found
differ
strain
strain
per
season
hrv
specimen
group
group
b
group
c
remain
could
type
appear
season
differ
preval
hrv
speci
fig
overal
april
virus
hrva
septemb
virus
hrvb
similar
number
hrvc
virus
detect
april
septemb
virus
detect
includ
enterovirus
adenovirus
advc
advb
coronavirus
influenza
virus
metapneumovirus
bocavirus
parainfluenza
virus
next
compar
list
hrv
strain
one
monitor
period
next
percentag
hrv
isol
carryov
strain
either
previou
season
previou
year
rang
strain
found
collect
period
tabl
ii
next
compar
weekli
viral
detect
rate
report
respiratori
symptom
overal
virus
detect
evalu
week
cold
symptom
vs
p
asthma
symptom
vs
p
like
occur
virusposit
compar
virusneg
week
see
tabl
articl
onlin
repositori
wwwjacionlineorg
addit
virusposit
week
associ
greater
peak
cold
sever
p
asthma
symptom
sever
p
tabl
iii
ill
classifi
one
separ
pattern
symptom
solitari
cold
symptom
solitari
asthma
symptom
combin
cold
asthma
symptom
viru
detect
rate
increas
week
either
cold
symptom
alon
combin
cold
asthma
symptom
solitari
asthma
symptom
report
viru
detect
rate
asymptomat
children
children
complet
least
season
data
collect
defin
ill
ill
viru
posit
viru
neg
virusposit
ill
associ
isol
cold
symptom
associ
isol
asthma
symptom
associ
overal
evid
ill
sever
presenc
viral
infect
tabl
iv
exampl
virusposit
ill
durat
cold
asthma
symptom
twice
long
loss
control
occur
much
frequent
vs
final
compar
rate
infect
virusposit
without
symptom
ill
defin
presenc
clinic
symptom
children
sensit
least
allergen
versu
children
complet
least
season
sensit
nonsensit
rate
infect
total
ill
number
nonvir
ill
per
month
april
septemb
similar
group
contrast
sensit
group
virusassoci
ill
per
season
vs
p
tabl
v
next
test
associ
sensit
sever
symptom
associ
document
viral
infect
nonsensit
children
commonli
report
none
mild
cold
symptom
viral
infect
wherea
almost
half
viral
infect
sensit
children
result
moder
sever
cold
symptom
p
trend
similarli
almost
half
viral
infect
sensit
children
result
moder
sever
asthma
symptom
half
viral
infect
nonsensit
children
report
asymptomat
p
trend
fig
peak
hrv
season
respiratori
virus
detect
half
weekli
sampl
obtain
schoolag
children
asthma
viral
infect
nearli
univers
april
septemb
although
virus
detect
hrv
made
vast
major
virus
detect
april
septemb
viral
strain
detect
singl
month
madison
wisconsin
area
specif
strain
hrv
differ
dramat
season
season
year
year
rel
strain
carri
studi
add
new
inform
pattern
differ
speci
rhinoviru
includ
newli
defin
hrvc
one
uniqu
featur
studi
evalu
children
asthma
peak
cold
season
irrespect
whether
asthma
symptom
cold
symptom
expect
hrv
infect
major
contributor
cold
asthma
symptom
howev
correl
viral
infect
ill
absolut
clearli
nonvir
factor
also
contribut
upper
lower
airway
symptom
children
mani
infect
asymptomat
comparison
viral
nonvir
ill
demonstr
viral
ill
last
longer
sever
like
associ
loss
asthma
control
final
children
allerg
sensit
similar
rate
viral
infect
significantli
increas
rate
sever
viral
ill
compar
children
sensit
rate
viral
infect
differ
base
age
season
presenc
respiratori
symptom
previou
studi
patient
asthma
respiratori
symptom
viral
detect
high
asymptomat
period
detect
rang
rel
high
viral
detect
rate
studi
like
result
sampl
symptomat
asymptomat
patient
period
peak
hrv
preval
particular
interest
extens
divers
hrv
strain
detect
one
commun
studi
period
almost
strain
detect
season
new
one
strain
detect
collect
period
find
substanti
agreement
earli
studi
hrv
epidemiolog
use
cultur
alon
detect
hrv
strain
add
new
inform
pattern
newli
defin
hrv
speci
although
strain
vari
season
season
year
year
speci
cluster
pattern
hrva
spring
hrvb
fall
hrvc
season
pattern
differ
report
previou
studi
hospit
children
asthma
hrvc
appear
predomin
fall
given
high
rate
chang
longer
period
evalu
need
firm
conclus
reach
regard
season
hrv
speci
high
rate
viral
detect
peak
hrv
season
suggest
caution
need
assign
causal
hrv
detect
pattern
respiratori
tract
ill
fact
viral
detect
alway
associ
cold
symptom
asthma
symptom
symptom
also
found
virusneg
week
hand
posit
correl
viral
infect
asthma
symptom
sever
addit
found
viral
ill
sever
longer
durat
cold
asthma
symptom
loss
asthma
control
compar
seen
nonvir
ill
find
suggest
viral
infect
close
associ
signific
cold
asthma
symptom
combin
viral
nonvir
factor
might
necessari
produc
sever
symptom
great
interest
defin
potenti
interact
allergi
viral
infect
promot
acut
respiratori
symptom
two
third
subject
sensit
least
allergen
test
sensit
number
infect
experienc
viral
respiratori
tract
ill
increas
sever
cold
asthma
symptom
compar
nonsensit
children
furthermor
nonsensit
children
like
experi
asymptomat
infect
would
appar
without
routin
sampl
nasal
secret
result
consist
observ
previou
studi
suggest
sensit
aeroallergen
signific
risk
factor
might
critic
sever
viral
ill
furthermor
also
suggest
sensit
allergen
exposur
viral
infect
alon
act
independ
risk
factor
asthma
hospit
rather
increas
risk
combin
current
effect
antivir
treatment
common
cold
virus
need
clinic
studi
determin
whether
control
allerg
inflamm
effect
strategi
reduc
risk
sever
virusinduc
asthma
symptom
allerg
subject
strength
current
studi
includ
prospect
studi
design
weekli
sampl
nasal
mucu
regardless
symptom
use
sensit
molecularbas
viral
diagnost
includ
molecular
type
comparison
viral
versu
nonvir
ill
limit
studi
includ
absenc
children
without
asthma
modest
sampl
size
base
find
j
allergi
clin
immunol
volum
number
studi
current
conduct
larger
studi
includ
children
without
asthma
focu
identifi
addit
host
viral
characterist
associ
ill
sever
conclus
studi
shown
nearli
children
asthma
infect
virus
peak
common
cold
season
mani
hrv
strain
move
commun
given
month
mani
strain
associ
loss
asthma
control
includ
newli
discov
hrvc
speci
virus
addit
studi
need
determin
whether
specif
characterist
virus
promot
wheez
acut
asthma
data
also
show
respiratori
tract
ill
associ
virus
sever
longer
durat
provid
evid
interact
allergi
virusinduc
respiratori
morbid
understand
mechan
interact
might
key
design
novel
effect
treatment
prevent
strategi
virusinduc
exacerb
asthma
